{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:21:56Z","timestamp":1791364916737,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jdcr.2025.01.014","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T01:47:12Z","timestamp":1738806432000},"page":"147-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Successful treatment of recalcitrant cutaneous lichen planus and unusual variants with upadacitinib: A case series and a literature review of systemic Janus kinase inhibitors use in cutaneous lichen planus and lichen planopilaris"],"prefix":"10.1016","volume":"59","author":[{"given":"Megan E.","family":"McNamara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5661-5862","authenticated-orcid":false,"given":"Leonardo","family":"Tjahjono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2025.01.014_bib1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40257-024-00878-9","article-title":"Lichen planus: what is new in diagnosis and treatment?","volume":"25","author":"Tekin","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/exd.14226","article-title":"The inflammation in cutaneous lichen planus is dominated by IFN-\u03d2 and IL-21-A basis for therapeutic JAK1 inhibition","volume":"30","author":"Pietschke","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164080","article-title":"JAK3 as an emerging target for topical treatment of inflammatory skin diseases","volume":"11","author":"Alves de Medeiros","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jdcr.2025.01.014_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.archoralbio.2018.11.015","article-title":"IL-25 promotes Th2-type reactions and correlates with disease severity in the pathogenesis of oral lichen planus","volume":"98","author":"Wang","year":"2019","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173017","article-title":"Myeloid dendritic cells stimulated by thymic stromal lymphopoietin promote Th2 immune responses and the pathogenesis of oral lichen planus","volume":"12","author":"Yamauchi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jdcr.2025.01.014_bib6","article-title":"Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+ CD8+ T-cells","volume":"135","author":"Hwang","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdcr.2025.01.014_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jdcr.2022.10.019","article-title":"Rapid resolution of widespread cutaneous lichen planus and generalized pruritus in an elderly patient following treatment with dupilumab","volume":"30","author":"Kazemi","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2025.01.014_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jdcr.2022.11.011","article-title":"Lichen planus pemphigoides successfully treated with dupilumab","volume":"31","author":"Ch'en","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2025.01.014_bib9","first-page":"E8","article-title":"Dupilumab for the treatment of lichen planus","volume":"107","author":"Pousti","year":"2021","journal-title":"Cutis"},{"key":"10.1016\/j.jdcr.2025.01.014_bib10","article-title":"Refractory lichen planus: success with dupilumab","volume":"10","author":"Read","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib11","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1111\/jdv.19440","article-title":"Rapid and sustained improvement of cutaneous lichen planus with oral JAK1 inhibitors","volume":"38","author":"B\u00f6ll","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib12","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/ijd.17339","article-title":"Recalcitrant lichen planopilaris treated with upadacitinib: a case series","volume":"63","author":"Lasheras-P\u00e9rez","year":"2024","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdcr.2024.01.007","article-title":"Unilateral blaschkoid lichen planus successfully treated with upadacitinib","volume":"45","author":"Rosenbaum","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2025.01.014_bib14","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.36849\/JDD.7272","article-title":"Successful treatment of lichen planus with oral upadacitinib","volume":"22","author":"Zundell","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib15","article-title":"A case of extensive lichen planus treated with deucravacitinib","volume":"16","author":"Ball","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jdcr.2025.01.014_bib16","article-title":"A successful experience in treating lichen planus pemphigoides with tofacitinib: a case report","author":"Balighi","year":"2024","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdcr.2024.06.013","article-title":"Treatment of hypertrophic lichen planus using deucravacitinib","volume":"51","author":"Sood","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2025.01.014_bib18","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3585","article-title":"Tofacitinib in hypertrophic lichen planus","volume":"100","author":"Seiringer","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jdcr.2023.04.017","article-title":"Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus","volume":"37","author":"Youssef","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jdcr.2025.01.014_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.8066","article-title":"Successful treatment of resistant plantar ulcerative lichen planus with tofacitinib: a case report and comprehensive review of the literature","volume":"11","author":"Bazargan","year":"2023","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jdcr.2025.01.014_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12656","article-title":"Tofacitinib for the treatment of lichen planopilaris: a case series","volume":"31","author":"Yang","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jdcr.2025.01.014_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/bjd\/ljae181","article-title":"Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomised, placebo-controlled, proof-of-concept PRELUDE study","volume":"191","author":"Passeron","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdcr.2025.01.014_bib23","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jid.2022.01.015","article-title":"Ruxolitinib cream in the treatment of cutaneous lichen planus: a prospective, open-label study","volume":"142","author":"Brumfiel","year":"2022","journal-title":"J Invest Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512625000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:19:25Z","timestamp":1775186365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512625000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":23,"alternative-id":["S2352512625000384"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.01.014","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of recalcitrant cutaneous lichen planus and unusual variants with upadacitinib: A case series and a literature review of systemic Janus kinase inhibitors use in cutaneous lichen planus and lichen planopilaris","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}